This content is machine translated SGLT2 inhibitors Clear, simple language improves patient safety Sodium-glucose cotransporter 2 inhibitors (SGLT2i) were initially indicated as blood glucose-lowering drugs for type 2 diabetes. They are now widely used as first-line therapies for various indications, particularly heart failure...…
